In unlikely alliance, PhRMA sides with landlords in Calif. referendum on rent control
SAN FRANCISCO — The pharmaceutical industry’s most powerful lobbying group is opening its war chest to try to sway a policy fight with no clear connection to medicine or health care, spending a half-million dollars here to oppose a California ballot measure that would expand rent control protections across the state.
PhRMA’s contribution is unusual not for its size — $500,000 is a relatively small sum for the trade association — but because the group typically only involves itself in policy issues likely to impact its bottom line. In this fight, it is siding with landlords, developers, and real estate investors, mainly in California but with some headquartered in other states; PhRMA is the only large donor opposing the measure without ties to the housing industry.
The group says that it’s getting involved in the ballot measure at stake, called Proposition 10, because it fears passage could make housing harder to find
You’re reading a preview, subscribe to read more.
Start your free 30 days